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DEAR EDITOR, Psoriasis in children can be a challenging diagno-
sis: the clinical presentation is often more subtle, may occur
in covered sites and can be an unexpected diagnosis as psoria-
sis is often thought to occur at older ages.1,2 Poor recognition
and delayed diagnosis of psoriasis in children can lead to inad-
equate treatment and lack of monitoring for comorbidities
including juvenile psoriatic arthritis.3 Diagnostic criteria would
help both clinical practice and clinical research, but to
date there are none available.4 The aim of this study was to
agree a list of expert-derived diagnostic criteria for plaque
psoriasis in children using electronic Delphi (eDelphi) consen-
sus methodology.
The study was undertaken online in three rounds plus a
feedback round (December 2015 to April 2016). The study
protocol was registered on the Centre of Evidence Based Der-
matology website at the University of Nottingham. The defini-
tion of consensus was decided a priori as being when ≥70% of
participants agreed. The eDelphi follows the study design and
reporting guidance by Sinha et al.5 Members of the Interna-
tional Psoriasis Council with an interest in paediatric psoriasis
were invited to participate. As recommended by Akins et al.,
the eDelphi aimed to include a minimum of 20 expert partici-
pants.6
Round 1 presented 21 clinical features identified as fre-
quently occurring in paediatric psoriasis (< 18 years of age),
based on interviews with paediatric dermatologists and a scop-
ing review.7 Participants were asked to score the importance
of each clinical feature in making a diagnosis on a five-point
scale (very important, important, less important, not impor-
tant, not sure) and to suggest additional clinical features that
they considered were missing.
Round 2 provided participants with feedback on the distri-
bution of responses for each clinical feature. Changes were
also made to the wording of some items, in-line with partici-
pants’ feedback, and new clinical features suggested during
round 1 were added. Participants were asked to re-score the
importance of each item in the light of group feedback, to
score whether an item alone would support a diagnosis of
psoriasis (yes, no, unsure) and to suggest options for a scor-
ing algorithm.
Round 3 presented the list of diagnostic features that
reached consensus as being important for the diagnosis of
psoriasis, suggested a possible scoring algorithm to use with
the diagnostic criteria and calculated percentage responses for
whether an item alone would support a diagnosis. Participants
were asked to re-score the value of a single feature and vote
on the scoring algorithm.
In total, 41 participants completed round 1; of these, 34
(83%) went on to complete round 2, 31 (76%) completed
round 3 and 27 (66%) completed a feedback survey on the
agreed criteria. Across the three rounds, most participants had
over 20 years’ experience as a dermatologist (48–54%) and
over 20 years’ specialist interest in psoriasis (46–48%). Most
participants treated adults and children in their routine prac-
tice (56–65%). The participants represented 19 countries, and
over 60% of participants were from the United States, Canada,
Denmark, the Netherlands, Chile, Spain and Italy.
By the end of round 2, 16 diagnostic features reached con-
sensus (≥ 70% agreement) as being important for the diagno-
sis of plaque psoriasis in children (Table 1). Three diagnostic
features were identified as major criteria; that is, the presence
of any of these features alone would support a diagnosis of
plaque psoriasis. The remaining 13 diagnostic features were
identified as minor criteria; that is, the presence of any of
these features alone would not support a diagnosis of plaque
psoriasis. Overall, 48% of participants felt that in the absence
of at least one major criterion, three or more minor criteria
would support a diagnosis of psoriasis in children (scoring
algorithm). Supplementary data are available on direct applica-
tion to the corresponding author.
The strengths of the current study are that it was an interna-
tional consensus study with global experts in psoriasis, who fre-
quently treat children with psoriasis. Limitations include under-
representation of African and Asian participants. The diagnostic
ability of any individual criterion and the combination of crite-
ria that are most predictive for psoriasis are unknown. A diag-
nostic accuracy study is now underway to test the consensus
agreed criteria and to identify the combination of features with
the optimal diagnostic accuracy. This study will investigate if
the major criteria have sufficient diagnostic accuracy to indepen-
dently support a diagnosis of psoriasis, and whether criteria that
overlap with other skin diseases (i.e. are not predictive of psori-
asis) need to be removed.
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This eDelphi consensus study provides a list of expert
agreed diagnostic features and is the first step in developing
diagnostic criteria for plaque psoriasis in children.
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Table 1 The results of round 2 and round 3 of the eDelphi consensus study presenting the group percentage scores for each diagnostic feature
and categorization as major or minor criteria.
Diagnostic features that reached > 70% consensus as ‘very important’ or ‘important’
and included in the consensus agreed diagnostic criteria
Total % scores for
‘very important’
and ‘important’
% agreement that a
feature should be a major
or minor criterion
Major criteria
Scaly erythematous plaques on the extensor surfaces of the elbows and knees 100 9360
Scaly erythematous plaques on the trunk triggered by a sore throat or other infection 9710 7190
Raindrop plaques typical of guttate disease on the trunk or limbsa 9710 –b
Minor criteria
Scale and erythema in the scalp involving the hairline 9710 8710
Retro-auricular erythema (including behind the earlobes) 7350 6130
Scaly erythema inside the external auditory meatusa 7350 6330
Persistent well-demarcated erythematous scaly rash anywhere on the bodya 8820 9030
Fine scaly patches involving the upper thighs and buttocks 7060 5160
Well-demarcated erythematous rash in the napkin area involving the crural folds 7650 7420
Persistent erythema in the umbilicus 8830 6000
Nail pitting 9410 8065
Onycholysis of the nail(s) 9120 6670
Subungual hyperkeratosis of the nail(s) 9110 7330
Positive family history of psoriasis 9410 8000
Koebner phenomenon 8820 5860
Fusiform swelling of a toe or a finger suggestive of dactylitis 8530 8210
The following diagnostic features did not reach consensus after round 2: scaly scalp; retro-auricular skin splitting (including behind the ear-
lobes); persistent well-demarcated facial rash with fine or absent scale; persistent erythematous periorbital rash with fine or absent scale;
well-demarcated erythematous rash in the axilla(e); natal cleft erythema and/or skin splitting; persistent nappy rash; sleep not disturbed by
itch; absence of skin xerosis. aDiagnostic features suggested in the feedback from round 1 and included in round 2; b594% agreed this item
should be kept alongside ‘Scaly erythematous plaques on the trunk triggered by a sore throat or other infection’.
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